General Cannabis Corp
Trees Corporation operates as a cannabis retailer and cultivator in the United States. The company operates through Retail and Cultivation segments. The company offers cannabis flower, shake, wax, shatter, live resin, and other products, as well as joints, and vape cartridges and batteries; and gummies, taffy, hard candies, cookies, chocolate bars, and savory snacks. It also provides smoking acce… Read more
General Cannabis Corp (CANN) - Net Assets
Latest net assets as of December 2024: $-3.07 Million USD
Based on the latest financial reports, General Cannabis Corp (CANN) has net assets worth $-3.07 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($20.76 Million) and total liabilities ($23.84 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-3.07 Million |
| % of Total Assets | -14.79% |
| Annual Growth Rate | N/A |
| 5-Year Change | -406.85% |
| 10-Year Change | N/A |
| Growth Volatility | 1001.74 |
General Cannabis Corp - Net Assets Trend (2010–2024)
This chart illustrates how General Cannabis Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for General Cannabis Corp (2010–2024)
The table below shows the annual net assets of General Cannabis Corp from 2010 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-3.07 Million | -2172.71% |
| 2023-12-31 | $148.16K | -97.69% |
| 2022-12-31 | $6.41 Million | -33.32% |
| 2021-12-31 | $9.61 Million | +860.00% |
| 2020-12-31 | $1.00 Million | +136.48% |
| 2019-12-31 | $-2.74 Million | -160.27% |
| 2018-12-31 | $4.55 Million | +29.82% |
| 2017-12-31 | $3.51 Million | +115.33% |
| 2016-12-31 | $-22.88 Million | -10888.38% |
| 2015-12-31 | $-208.18K | +94.09% |
| 2014-12-31 | $-3.52 Million | -1679.16% |
| 2013-12-31 | $223.00K | +1438.04% |
| 2012-12-31 | $14.50K | -58.36% |
| 2011-12-31 | $34.82K | -7.03% |
| 2010-12-31 | $37.45K | -- |
Equity Component Analysis
This analysis shows how different components contribute to General Cannabis Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 10397718700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $108.75K | % |
| Other Components | $100.80 Million | % |
| Total Equity | $-3.07 Million | 100.00% |
General Cannabis Corp Competitors by Market Cap
The table below lists competitors of General Cannabis Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Presurance Holdings, Inc.
NASDAQ:PRHI
|
$2.21 Million |
|
Hudson Investment Group Ltd
AU:HGL
|
$2.21 Million |
|
Sakol Energy Public Company Limited
BK:SKE
|
$2.21 Million |
|
HIKARI TSUSHIN - Dusseldorf Stock Exchang
DU:HIK
|
$2.21 Million |
|
Vidhance AB (publ)
F:8W50
|
$2.21 Million |
|
Weststar Industrial Ltd
AU:WSI
|
$2.21 Million |
|
Askari Metals Ltd
AU:AS2
|
$2.21 Million |
|
Sambhaav Media Limited
NSE:SAMBHAAV
|
$2.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in General Cannabis Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 148,159 to -3,070,900, a change of -3,219,059 (-2172.7%).
- Net loss of 3,480,966 reduced equity.
- Other factors increased equity by 261,907.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.48 Million | -113.35% |
| Other Changes | $261.91K | +8.53% |
| Total Change | $- | -2172.71% |
Book Value vs Market Value Analysis
This analysis compares General Cannabis Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | $0.00 | $0.04 | x |
| 2010-12-31 | $0.00 | $0.04 | x |
| 2011-12-31 | $0.00 | $0.04 | x |
| 2012-12-31 | $0.00 | $0.04 | x |
| 2014-12-31 | $-0.26 | $0.04 | x |
| 2015-12-31 | $-0.01 | $0.04 | x |
| 2016-12-31 | $-1.48 | $0.04 | x |
| 2017-12-31 | $0.17 | $0.04 | x |
| 2018-12-31 | $0.13 | $0.04 | x |
| 2019-12-31 | $-0.07 | $0.04 | x |
| 2020-12-31 | $0.02 | $0.04 | x |
| 2021-12-31 | $0.14 | $0.04 | x |
| 2022-12-31 | $0.07 | $0.04 | x |
| 2023-12-31 | $0.00 | $0.04 | x |
| 2024-12-31 | $-0.03 | $0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently General Cannabis Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -25.49%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-453.77%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | -100.70% | -85.27% | 1.18x | 1.00x | $-35.62K |
| 2010 | -1.94% | -0.72% | 2.59x | 1.04x | $-4.47K |
| 2011 | -168.52% | -95.32% | 1.76x | 1.00x | $-62.17K |
| 2012 | -140.17% | -96.63% | 1.40x | 1.03x | $-21.77K |
| 2014 | 0.00% | -2885.08% | 0.12x | 0.00x | $-6.58 Million |
| 2015 | 0.00% | -498.38% | 0.48x | 0.00x | $-8.77 Million |
| 2016 | 0.00% | -1099.93% | 1.04x | 0.00x | $-30.51 Million |
| 2017 | -234.48% | -233.41% | 0.46x | 2.17x | $-8.57 Million |
| 2018 | -372.94% | -367.50% | 0.43x | 2.36x | $-17.43 Million |
| 2019 | 0.00% | -404.43% | 1.05x | 0.00x | $-14.55 Million |
| 2020 | -767.36% | -107.86% | 0.84x | 8.51x | $-7.78 Million |
| 2021 | -92.32% | -149.64% | 0.27x | 2.29x | $-9.83 Million |
| 2022 | -147.98% | -70.52% | 0.42x | 4.95x | $-10.12 Million |
| 2023 | -4780.17% | -39.05% | 0.78x | 156.91x | $-7.10 Million |
| 2024 | 0.00% | -25.49% | 0.66x | 0.00x | $-3.17 Million |
Industry Comparison
This section compares General Cannabis Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| General Cannabis Corp (CANN) | $-3.07 Million | -100.70% | N/A | $2.21 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |